Oral administration of S-892216 or placebo

2 trials

Sponsors

Gomez Juan Carlos

Conditions

COVID-19

Phase 1

A Phase 1 Study of S-892216 (COVID-19)

Active, not recruitingJPRN-jRCT2031230082

Gomez Juan CarlosCOVID-19

Start: 2023-05-01Target: 347Updated: 2026-06-29

Phase 2

Phase 2 study of S-892216 in participants infected with SARS-CoV-2(COVID-19)

Active, not recruitingJPRN-jRCT2031250144

Gomez Juan CarlosCOVID-19

Start: 2025-06-06Target: 280Updated: 2026-06-29